Income StatementBalance SheetCash FlowSegments
KLR

Kailera Therapeutics Income Statement

Revenue, expenses, and profitability over time
Operating Income-$84.7MNet Income-$78.9MEps Diluted$-3650.00
Market Cap$2.8B

Other Income & Expense

MetricQ1 '25Q1 '26
Derivative Gain (Loss) Excluded from Effectiveness$1.7M$5.7M
Interest Income (Expense), Non-operating$1.7M$5.7M
Non-operating Income$800.0K$79.0K
Other Charges$2.5M$5.8M
Interest expense$1.7M$5.7M
Interest Income (Expense), Nonoperating$1.7M$5.7M
Other income (expense), net$2.5M$5.8M
Non-operating Interest Income (Expense)$1.7M$5.7M

Other

MetricQ1 '25Q1 '26
OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax-$6.0K-$761.0K
Unrealized Gain (Loss) on Securities-$6.0K-$761.0K
OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax-$6.0K-$761.0K
Comprehensive Income (Loss), Net of Tax, Attributable to Parent-$18.0M-$79.6M
Net unrealized gains (losses) on securities still held-$6.0K-$761.0K
Other income, net (Note 6)$2.5M$5.8M
Other Comprehensive Income (Loss)-$18.0M-$79.6M

Earnings Per Share

MetricQ1 '25Q1 '26
Basic earnings per share$-17983.00$-3650.00
Diluted earnings per share$-17983.00$-3650.00
Weighted-average shares, basic121.6K
Weighted-average shares, diluted121.6K

Operating Expenses

MetricQ1 '25Q1 '26
General and administrative$10.3M$13.8M
Other operating expenses$20.5M$84.7M
Research and development$10.1M$70.9M
Total operating expenses$20.5M$84.7M

Net Income

MetricQ1 '25Q1 '26
Net income-$18.0M-$78.9M

Operating Income

MetricQ1 '25Q1 '26
Operating income-$20.5M-$84.7M